Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TT3NH7G)

DTT Name	Human immunodeficiency virus Deoxyribonucleic acid (HIV DNA)
Gene Name	HIV DNA
DTT Type	Clinical trial target	[1]
UniProt ID	NOUNIPROTAC
TTD ID	T29525

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This DTT

2 Clinical Trial Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
CI-1012	DMLRTN1	Acquired immune deficiency syndrome	1C62.3	Phase 2	[1]
PBSVax	DMMR4E7	Human immunodeficiency virus infection	1C62	Phase 1	[2]
------------------------------------------------------------------------------------

References

1	WO patent application no. 2006,0835,53, Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase.
2	ClinicalTrials.gov (NCT01578889) Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults. U.S. National Institutes of Health.